Caretolive v. Von Eschenbach

OPINION AND ORDER

GREGORY L. FROST, District Judge.

This action involves a biologies license application (“BLA”) that was submitted to the Food and Drug Administration (“FDA”) for Provenge, a biological product which is intended to treat a particular type of metastatic prostate cancer and is manufactured by Dendreon Corporation. Plaintiff CareToLive challenges the decision of the FDA “not to approve Provenge for immediate use and instead [to] issue[] a Complete Response Letter requesting more data.” (Doc. # 22.)

This matter is before the Court on Plaintiffs Motion for Order that the FDA Comply…